Evidence map›Paper›PMID 41194659›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2025

Acyclic graphs to define models of relationships between human cytomegalovirus, cardiovascular disease and all-cause mortality in UK Biobank.

Robert Doorly, Amanda Y Chong, Elizabeth Hamilton, Thomas J Littlejohns, Julian C Knight, Seilesh Kadambari, Paul Klenerman, Alexander J Mentzer

Abstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Acyclic graphs to define models of relationships between human cytomegalovirus, cardiovascular disease and all-cause mortality in UK Biobank.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  2. The indirect effects of cytomegalovirus infection-mechanisms and consequences.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Robert DoorlySchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0SP, UK.
Amanda Y ChongCentre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Elizabeth HamiltonUniversity of Oxford Nuffield Department of Population Health, Oxford OX3 7LF, UK.
Thomas J LittlejohnsUniversity of Oxford Nuffield Department of Population Health, Oxford OX3 7LF, UK.
Julian C KnightCentre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Seilesh KadambariDepartment of Paediatric Infectious Diseases and Immunology, Great Ormond Street Hospital for Children, London WC1N 3BH, UK.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, UK.
Alexander J MentzerCentre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.ORCID 0000-0002-4502-2209

Funding

Janssen Research and DevelopmentWellcome Trust
6 · The paper itself

Abstract

Human cytomegalovirus seropositivity has shown varying levels of association with cardiovascular disease and all-cause mortality in previous studies. This study uses updated data from the UK Biobank to test these associations. The association between human cytomegalovirus seropositivity and outcomes of incident cardiovascular disease, ischaemic heart disease, stroke and all-cause mortality was determined using multivariate Cox proportional-hazards models in 8740 UK Biobank participants aged 40-69 years. Two directed acyclic graphs depicting the hypothesized relationship between human cytomegalovirus infection (either in childhood or adulthood) and cardiovascular disease/all-cause mortality controlled the selection of biological and socioeconomic confounders to be adjusted for in each model. Human cytomegalovirus seropositivity was not significantly associated with cardiovascular disease, ischaemic heart disease, stroke or all-cause mortality when applying either the fully adjusted adulthood or childhood infection models. We found no significant association between human cytomegalovirus seropositivity and any of the measured outcomes. Further research is expected to include larger sample sizes, younger participants and more ethnically diverse cohorts.This article is part of the discussion meeting issue 'The indirect effects of cytomegalovirus infection: mechanisms and consequences'.

Indexed as

Cardiovascular DiseasesCytomegalovirusCytomegalovirus InfectionsAdultAgedBiological Specimen BanksFemaleHumansMaleMiddle AgedProportional Hazards ModelsUK BiobankUnited Kingdomcardiovascular diseasecytomegalovirusmyocardial infarctionprospective studystrokeUK

Identifiers

PMID41194659
PMCPMC12590165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.